California Healthcare Institute Issues Statement on Supreme Court Ruling on the Affordabl... (La Jolla Calif. (PRWEB) June 28 2012 ...)

California Healthcare Institute Issues Statement on Supreme Court Ruling on the Affordable Care Act

Date:6/28/2012

La Jolla, Calif. (PRWEB) June 28, 2012

CHI-California Healthcare Institute President and Chief Executive Officer David L. Gollaher, Ph.D., issued the following statement regarding today’s Supreme Court ruling on the Affordable Care Act:

“The Supreme Court's ruling, finding most provisions of the Affordable Care Act constitutional, surprised almost everyone. Chief Justice John Roberts, writing for the 5-4 majority, said that the Act's individual mandate could stand, not, as the Obama Administration argued, under the Constitution's Commerce Clause, but based on congressional authority to impose taxes. As for the Act's enormous expansion of Medicaid, seven justices (all except Justices Ginsburg and Sotomayor) held that it went too far in imposing potential penalties on the states for noncompliance. Medicaid will expand, but how this plays out will take weeks and months to understand.
“Meanwhile, the Court's decision leaves important parts of the Act untouched. These include the medical device excise tax, the authority for FDA to create a pathway for approving biosimilars, and the Independent Payment Advisory Board.

“CHI will continue to work with policymakers to ensure implementation of the law enabling the biomedical community in California to continue to develop lifesaving therapies and medical technology while protecting patient access to critical medical innovation. CHI will continue to support implementation of the bipartisan-supported biosimilars pathway, including its critical provision providing 12-years of data exclusivity that was enacted under the Affordable Care Act. CHI will also work to support efforts to repeal the Independent Payment Advisory Board, or IPAB, which threatens patient access to important and innovative medical interventions.

“CHI has also strongly opposed the medical device excise tax and will continue to work to support its repeal. Our nation’s medical technology compan
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. Synteract and MediciNova Partner in "Fight For Air Walk" to Support the American Lung Association in California
2. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
3. Epitomics, Inc. and University of California, Davis, Complete Star Program for High-Throughput Measurement of Antibody-Antigen Interactions
4. Agendia Signs Contract with Blue Shield of California
5. Intellect Neurosciences Enters Collaboration Agreement with Leading Alzheimers Research Group at University of California Irvine to Test First in Class Dual Target Vaccine
6. Synthetic Genomics Inc. Purchases 81 Acre Site in South California Desert for Scale up and Testing of Innovative Algae Strains
7. Pacific BioStorage Announces an Exciting New First for The Life Sciences Industry in Southern California
8. Lightning Brewery’s Craft Beer Old Tempestuous Ale Wins Best of Show at 2012 California State Fair Commercial Brewing Competition
9. Californians Take One Step Closer to Directly Accessing Physical Therapy Services for Immediate Treatment
10. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
11. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon

Post Your Comments:

(Date:5/21/2013)... Milwaukee, Wisc. (PRWEB) May 21, 2013 ... equipment parts distributor , will be exhibiting for ... the Advancement of Medical Instrumentation (AAMI) 2013 Conference ... manage, purchase, support, distribute, and manufacture healthcare technologies. ... 1-3 in Long Beach, California. , The ...

(Date:5/21/2013)... 2013 Clinverse, Inc. , ... clinical trials, announced today it has formed a ... Clinverse’s ClinPay® FLS eClinical commerce platform aggregates data ... SpendMD ™, Aggregate Spend Solutions’ recently-launched flagship ... and reporting transfer of value at investigator meetings ...

(Date:5/21/2013)... 2013 As the R&D sector ... within the industry to deliver better products, faster. ... pharma companies often means turning big ideas into ... in collaboration with Sensidose AB and Recipharm, is ... products to market sooner. The partnership resulted in ...

(Date:5/21/2013)... Md. , May 21, 2013 MacroGenics, ... 1 study of margetuximab (MGAH22), an Fc-modified chimeric ... tumors expressing the HER2 oncoprotein," will be presented ... Society of Clinical Oncology during the Developmental Therapeutics ... 3 at 4:15 – 4:30 PM. The presentation ...

Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2 Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2 Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3 The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2 MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2 MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3

[0] Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo [0] Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC [0] The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks [0] MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer

... 7, 2011 Reportlinker.com ... report is available in its catalogue: ... Shares, Strategies, and Forecasts, Worldwide, 2011 ... http://www.reportlinker.com/p0569001/Tele-Health-Monitoring-Market-Shares-Strategies-and-Forecasts-Worldwide-2011-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=e-Healthcare WinterGreen Research ...

... is available in German . ... supplements. However, the production of this "functional food" has ... enough to survive conventional production processes. Researchers from Technische ... that allows the use of thus far unutilized probiotics. ...

... are among the oldest known life-forms, but they are ... that these single-celled microorganisms were designated as a domain ... eukaryotes. Robert Gunsalus, a UCLA professor ... in Archaea because of their ability to ...

Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 TUM researchers develop environmentally friendly process to improve storage stability of probiotics Old life capable of revealing new tricks after all

(Date:5/21/2013)... Researchers at the University of Illinois at Chicago College of ... and stores fat -- its main energy source -- and ... disease, under a new $2 million, 4-year grant from the ... heart changes how it uses fuel for energy. These changes ... disease and are different in men and women, says E. ...

(Date:5/21/2013)... charted the path of insulin action in cells in ... blueprint for understanding what goes wrong in diabetes. ... Professor David James from Sydney,s Garvan Institute of Medical ... of the prestigious journal Cell Metabolism . , ... very important role in the body because it helps ...

(Date:5/20/2013)... is known about the effect of physical education (PE) ... University finds that increasing the amount of time that ... of obesity. , The study represents some of the ... youth obesity, and is forthcoming in the Journal ... of the study can be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 ...

Breaking Biology News(10 mins):Do men's and women's hearts burn fuel differently? 2 Insight into the dazzling impact of insulin in cells 2 Insight into the dazzling impact of insulin in cells 3 Gym class reduces probability of obesity, study finds for first time 2

[0] Do men's and women's hearts burn fuel differently?[0] Insight into the dazzling impact of insulin in cells [0] Gym class reduces probability of obesity, study finds for first time

... A study published in this week,s online issue of ... sensitive method for detecting methylation-associated cancers. ... of methyl groups has been established as a common ... levels of DNA methylation, which effectively disrupt the genes ...

... research shows that air pollution in eastern China has reduced ... and decreased by 23 percent the number of days of ... results suggest that bad air quality might be affecting the ... health and environmental problems. The study links for the ...

... Dresden research team used laser tweezers to measure the ... track. The team found that also within our ... are restrained in its operationusually by far not as ... experimental measurements of protein friction could help researchers to ...

Cached Biology News:Researchers develop new, more-sensitive assay for detecting DNA methylation in colon cancer 2 Researchers develop new, more-sensitive assay for detecting DNA methylation in colon cancer 3 The sky is not falling: Pollution in eastern China cuts light, useful rainfall 2 The sky is not falling: Pollution in eastern China cuts light, useful rainfall 3 The sky is not falling: Pollution in eastern China cuts light, useful rainfall 4 Bionanomachines -- proteins as resistance fighters 2

Researchers develop new, more-sensitive assay for detecting DNA methylation in colon cancer The sky is not falling: Pollution in eastern China cuts light, useful rainfall Bionanomachines -- proteins as resistance fighters

Request Info...

Applications: (+) Immunocytochemistry and immunohistochemistry...

RABBIT ANTI WARFARIN...

Request Info...

Biology Products:

Rat IFN-gamma ELISpot Development Kit from R&D Systems Normal Goat Serum from Cayman Chemical Rabbit Anti-WARFARIN Polyclonal Antibody, Unconjugated from AbD Serotec MagCellect Rat CD4+ T Cell Isolation Kit from R&D Systems